The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Treatment of Tics and Tourette Syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although many patients with tic disorders do use complementary and alternative medical therapies, 153 support for this practice is not currently at the evidence based level.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Behavior Therapy for Children With Tourette Disorder: A Randomized Controlled Trial
Piacentini, J., Woods, D. W., Scahill, L., Wilhelm, S., Peterson, A. L., Chang, S., Ginsburg, G. S., Deckersbach, T., Dziura, J., Levi-Pearl, S., et al. (2010) · JAMA · doi:10.1001/jama.2010.607 · Cited by 790
Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., & Swedo, S. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12297-3 · Cited by 556
Treatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A., & Leckman, J. F. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b26e9f · Cited by 270
Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., & Emrich, H. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0417 · Cited by 270
Deckersbach, T., Rauch, S., Buhlmann, U., & Wilhelm, S. (2006) · Behaviour Research and Therapy · doi:10.1016/j.brat.2005.08.007 · Cited by 231
KHALIFA, N., & VON KNORRING, A. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01837.x · Cited by 179
First-onset tics in patients with attention-deficit–hyperactivity disorder: impact of stimulants
Roessner, V., Robatzek, M., Knapp, G., Banaschewski, T., & Rothenberger, A. (2006) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162206001290 · Cited by 70
Research works printed but not linked: 80
- Singer HS: Tourette’s syndrome: from behaviour to biology. Lancet Neurol 2005, 4:149–159. · DOI · Paper page
- Walkup JT, Ferrao Y, Leckman JF, et al.: Tic disorders: some key issues for DSM-V. Depress Anxiety 2010, 27:600–610. · DOI
- Kurlan R, Como PG, Miller B, et al.: The behavioral spectrum of tic disorders: a community-based study. Neurology 2002, 59:414–420. · DOI · Paper page
- Cavanna AE, Eddy C, Rickards HE: Cognitive functioning in Tourette syndrome. Discov Med 2009, 8:191–195.
- Pringsheim T, Lang A, Kurlan R, et al.: Understanding disability in Tourette syndrome. Dev Med Child Neurol 2009, 51:468–472. · DOI
- Mejia NI, Jankovic J: Secondary tics and tourettism. Rev Bras Psiquiatr 2005, 27:11–17. · DOI
- Bergin A, Waranch HR, Brown J, et al.: Relaxation therapy in Tourette syndrome: a pilot study. Pediatr Neurol 1998, 18:136–142. · DOI
- O’Connor KP, Laverdure A, Taillon A, et al.: Cognitive behavioral management of Tourette’s syndrome and chronic tic disorder in medicated and unmedicated samples. Behav Res Ther 2009, 47:1090–1095. · DOI
- Woods DW, Piacentini JC, Chang SW, et al.: Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults. New York: Oxford University Press; 2008. Woods DW, Piacentini JC, Chang SW, et al.: Managing Tourette Syndrome: A Behavioral Intervention for Children and Adults. New York: Oxford University Press; 2008.
- Himle MB, Woods DW, Piacentini JC, Walkup JT: Brief review of habit reversal training for Tourette syndrome. J Child Neurol 2006, 21:719–725. · DOI · Paper page
- Garcia-Lopez R, Romero-Gonzalez J, Perea-Milla E, et al.: [An open study evaluating the efficacy and security of magnesium and vitamin B(6) as a treatment of Tourette syndrome in children.]. Med Clin (Barc) 2008, 131:689–692. · doi:10.1157/13129113
- Ma S, Liu XY, Yu RL, Chen LJ: [Clinical observation on acupuncture for treatment of Tourette’s syndrome]. Zhongguo Zhen Jiu 2006, 26:392–394.
- Mantovani A, Lisanby SH, Pieraccini F, et al.: Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette’s syndrome (TS). Int J Neuropsychopharmacol 2006, 9:95–100. · DOI · Paper page
- Mantovani A, Leckman JF, Grantz H, et al.: Repetitive transcranial magnetic stimulation of the supplementary motor area in the treatment of Tourette syndrome: report of two cases. Clin Neurophysiol 2007, 118:2314–2315. · DOI
- Scahill L, Erenberg G, Berlin CM Jr, et al.: Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 2006, 3:192–206. · DOI · Paper page
- Hedderick EF, Morris CM, Singer HS: Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome. Pediatr Neurol 2009, 40:420–425. · DOI · Paper page
- Gaffney GR, Perry PJ, Lund BC, et al.: Risperidone versus clonidine in the treatment of children and adolescents with Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330–336. · DOI · Paper page
- Du YS, Li HF, Vance A, et al.: Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders. Aust NZ J Psychiatry 2008, 42:807–813. · DOI · Paper page
- Scahill L, Chappell PB, Kim YS, et al.: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067–1074. · DOI · Paper page
- Cummings DD, Singer HS, Krieger M, et al.: Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 2002, 25:325–332. · DOI
- Abuzzahab FS, Brown VL: Control of Tourette’s syndrome with topiramate. Am J Psychiatry 2001, 158:968. · DOI
- Kuo SH, Jimenez-Shahed J: Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol 2010, 33:32–34. · DOI
- Jankovic J, Jimenez-Shahed J, Brown LW: A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry 2009, 81:70–73. · DOI · Paper page
- Awaad Y, Michon AM, Minarik S: Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome. Mov Disord 2005, 20:714–718. · DOI
- Fernandez-Jaen A, Fernandez-Mayoralas DM, Munoz-Jareno N, Calleja-Perez B: An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome. Eur J Paediatr Neurol 2009, 13:541–545. · DOI
- Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS: A double blind randomized placebo control trial of levetiracetam in Tourette syndrome. Mov Disord 2007, 22:1764–1770. · DOI · Paper page
- Shapiro AK: Gilles de la Tourette Syndrome. New York: Raven; 1988.
- Awaad Y: Tics in Tourette syndrome: new treatment options. J Child Neurol 1999, 14:316–319. · DOI
- Singer HS, Wendlandt J, Krieger M, Giuliano J: Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001, 56:599–604. · DOI
- Drtilkova I, Balaotkova B, Lemanova H, Zak J: Therapeutical effects of clonidine and clonazepam in children with tic syndrome. Homeost Health Dis 1994, 35:296.
- Schneeweiss S, Avorn J: Antipsychotic agents and sudden cardiac death—How should we manage the risk? N Engl J Med 2009, 360:294–296. · DOI
- Pringsheim T, Marras C: Pimozide for tics in Tourette’s syndrome. Cochrane Database Syst Rev 2009, CD006996. This comprehensive review of prior studies assessed the benefits and risks of pimozide in comparison to placebo or other medications in treating tics in Tourette syndrome. · DOI · Paper page
- Singer HS, Gammon K, Quaskey S: Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Pediatr Neurosci 1985, 12:71–74. · DOI
- Goetz CG, Tanner CM, Klawans HL: Fluphenazine and multifocal tic disorders. Arch Neurol 1984, 41:271–272. · DOI
- Jankovic J: Treatment of hyperkinetic movement disorders. Lancet Neurol 2009, 8:844–856. · DOI · Paper page
- Shapiro E, Shapiro AK, Fulop G, et al.: Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette’s syndrome. Arch Gen Psychiatry 1989, 46:722–730. · DOI · Paper page
- Dion Y, Annable L, Sandor P, Chouinard G: Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31–39. · DOI · Paper page
- Bruggeman R, van der Linden C, Buitelaar JK, et al.: Risperidone versus pimozide in Tourette’s disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001, 62:50–56. · DOI · Paper page
- Gilbert DL, Batterson JR, Sethuraman G, Sallee FR: Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004, 43:206–214. · DOI
- Budman C, Coffey BJ, Shechter R, et al.: Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts. J Child Adolesc Psychopharmacol 2008, 18:509–515. · DOI · Paper page
- Kawohl W, Schneider F, Vernaleken I, Neuner I: Chronic motor tic disorder and aripiprazole. J Neuropsychiatry Clin Neurosci 2009, 21:224. · doi:10.1176/appi.neuropsych.21.2.224
- Murphy TK, Mutch PJ, Reid JM, et al.: Open label aripiprazole in the treatment of youth with tic disorders. J Child Adolesc Psychopharmacol 2009, 19:441–447. · DOI · Paper page
- Davies L, Stern JS, Agrawal N, Robertson MM: A case series of patients with Tourette’s syndrome in the United Kingdom treated with aripiprazole. Hum Psychopharmacol 2006, 21:447–453. · DOI
- Seo WS, Sung HM, Sea HS, Bai DS: Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder. J Child Adolesc Psychopharmacol 2008, 18:197–205. · DOI
- Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette’s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292–299. · DOI · Paper page
- Willmund G, Lee AH, Wertenauer F, et al.: Vocal tics associated with ziprasidone. J Clin Psychopharmacol 2009, 29:611–612. · doi:10.1097/jcp.0b013e3181c06dad
- Budman CL, Gayer A, Lesser M, et al.: An open-label study of the treatment efficacy of olanzapine for Tourette’s disorder. J Clin Psychiatry 2001, 62:290–294. · DOI
- McCracken JT, Suddath R, Chang S, et al.: Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome. J Child Adolesc Psychopharmacol 2008, 18:501–508. · DOI · Paper page
- Onofrj M, Paci C, D’Andreamatteo G, Toma L: Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 2000, 247:443–446. · DOI
- Mukaddes NM, Abali O: Quetiapine treatment of children and adolescents with Tourette’s disorder. J Child Adolesc Psychopharmacol 2003, 13:295–299. · DOI
- Copur M, Arpaci B, Demir T, Narin H: Clinical effectiveness of quetiapine in children and adolescents with Tourette’s syndrome: a retrospective case-note survey. Clin Drug Investig 2007, 27:123–130. · DOI
- Kenney C, Hunter C, Jankovic J: Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007, 22:193–197. · DOI · Paper page
- Kenney C, Hunter C, Davidson A, Jankovic J: Short-term effects of tetrabenazine on chorea associated with Huntington’s disease. Mov Disord 2007, 22:10–13. · DOI
- Porta M, Sassi M, Cavallazzi M, et al.: Tourette’s syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig 2008, 28:443–459. · DOI
- Simpson DM, Blitzer A, Brashear A, et al.: Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1699–1706. · DOI · Paper page
- Marras C, Andrews D, Sime E, Lang AE: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology 2001, 56:605–610. · DOI · Paper page
- Kwak CH, Hanna PA, Jankovic J: Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190–1193. · DOI · Paper page
- Rath JJ, Tavy DL, Wertenbroek AA, et al.: Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects. Parkinsonism Relat Disord 2010, 16:478–481. · DOI
- Porta M, Maggioni G, Ottaviani F, Schindler A: Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A. Neurol Sci 2004, 24:420–423. · DOI
- Robertson MM, Schnieden V, Lees AJ: Management of Gilles de la Tourette syndrome using sulpiride. Clin Neuropharmacol 1990, 13:229–235. · DOI
- Ho CS, Chen HJ, Chiu NC, et al.: Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc 2009, 108:788–793. · DOI
- Eggers C, Rothenberger A, Berghaus U: Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride. Eur Arch Psychiatry Neurol Sci 1988, 237:223–229. · DOI
- Singer HS, Morris C, Grados M: Glutamatergic modulatory therapy for Tourette syndrome. Med Hypotheses 2010, 74:862–867. · DOI
- Cubo E, Fernandez Jaen A, Moreno C, et al.: Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study. Clin Ther 2008, 30:182–189. · DOI
- Bortolato M, Muroni A, Marrosu F: Treatment of Tourette’s syndrome with finasteride. Am J Psychiatry 2007, 164:1914–1915. · DOI
- Peterson BS, Zhang H, Anderson GM, Leckman JF: A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette’s syndrome. J Clin Psychopharmacol 1998, 18:324–331. · DOI
- Bonnier C, Nassogne MC, Evrard P: Ketanserin treatment of Tourette’s syndrome in children. Am J Psychiatry 1999, 156:1122–1123. · DOI
- Hoekstra PJ, Minderaa RB, Kallenberg CG: Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study. J Clin Psychiatry 2004, 65:537–542. · DOI
- Neimat JS, Patil PG, Lozano AM: Novel surgical therapies for Tourette syndrome. J Child Neurol 2006, 21:715–718. · DOI
- Porta M, Sassi M, Ali F, et al.: Neurosurgical treatment for Gilles de la Tourette syndrome: the Italian perspective. J Psychosom Res 2009, 67:585–590. · DOI
- Mink JW: Clinical review of DBS for Tourette syndrome. Front Biosci (Elite Ed) 2009, 1:72–76.
- Mink JW: Clinical review of DBS for Tourette syndrome. Front Biosci (Elite Ed) 2009, 1:72–76. · DOI · Paper page
- Shields DC, Cheng ML, Flaherty AW, et al.: Microelectrode-guided deep brain stimulation for Tourette syndrome: within-subject comparison of different stimulation sites. Stereotact Funct Neurosurg 2008, 86:87–91. · DOI
- Temel Y, Visser-Vandewalle V: Surgery in Tourette syndrome. Mov Disord 2004, 19:3–14. · DOI · Paper page
- Erenberg G: The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Semin Pediatr Neurol 2005, 12:217–221. · DOI
- Allen AJ, Kurlan RM, Gilbert DL, et al.: Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 2005, 65:1941–1949. · DOI · Paper page
- Singer HS, Brown J, Quaskey S, et al.: The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995, 95:74–81. · DOI · Paper page
- Spencer T, Biederman J, Coffey B, et al.: A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2002, 59:649–656. · DOI · Paper page
- Storch EA, Bjorgvinsson T, Riemann B, et al.: Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. Bull Menninger Clin 2010, 74:167–185. · DOI
- Decloedt EH, Stein DJ: Current trends in drug treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat 2010, 6:233–242. · DOI
Cited by
Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry
Robbins, T. W., Gillan, C. M., Smith, D. G., de Wit, S., & Ersche, K. D. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.009 · Cited by 1,003
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Advances in understanding and treatment of Tourette syndrome
McNaught, K. S. P., & Mink, J. W. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.167 · Cited by 196
Metadata
- Authors
- Singer, H. S.
- Venue
- Current Treatment Options in Neurology
- Published
- 2010-09-10
- Volume
- 12
- Issue
- 6
- Pages
- 539-561
- ISSN
- 1092-8480
- 1534-3138
- Cited by
- 97
- References
- 11
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of Tics and Tourette Syndrome. https://app.cochat.ai/papers/10.1007/s11940-010-0095-4
- The paper
- Singer, H. S. (2010). Treatment of Tics and Tourette Syndrome. Current Treatment Options in Neurology. https://doi.org/10.1007/s11940-010-0095-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.